Asthenia and vascular cognitive impairment in young patients after stroke
Open Access
- 19 October 2024
- journal article
- Published by IMA Press, LLC in Neurology, Neuropsychiatry, Psychosomatics
- Vol. 16 (5) , 69-76
Abstract
Post-stroke cognitive impairment (PSCI) is found in most patients over 50 years of age. At a young age, PSCI has a negative impact on daily activities, quality of life and return to work, regardless of physical recovery. Often PSCI are combined with asthenia, but there is very little information on the prevalence of post-stroke asthenia (PSA). Currently, the treatment of PSCI and PSA in young patients with citicoline is still controversial.Objective: to evaluate the prevalence of PSCI and PSA in young patients and the efficacy and safety of the domestic drug Noocil (citicoline) in the treatment of PSCI and PSA in stroke patients of young age.Material and methods. The work was conducted in two stages: the first stage was a longitudinal study of cognitive status using neurocognitive scales and assessment of signs of asthenia in patients aged 18 to 45 years; the second stage was an open prospective observational study of 47 patients aged 18 to 45 years with confirmed ischemic stroke (IS) who were randomly assigned to groups with Noocil administration (main group; n=26) or without treatment (control group; n=21). Cognitive function was assessed by Montreal Cognitive Assessment (MoCA) and asthenia by manifestations of general fatigue (Multidimensional Fatigue Inventory, MFI-20).Results. High frequency of PSCI (51%) and the severity of asthenia according to MFI-20 scale were found in the hospital sample of young patients with IS. A direct correlation was found between the severity of PSA and the degree of cognitive decline. The positive effect of Noozil on cognitive functions, emotional state and severity of asthenia in the study group was noted. At the end of treatment, the mean MoCA score was 27.4±1.4 in the main group and 25.9±1.1 in the control group (pConclusion. The high incidence of PSCI and PSA and the positive effect of Noocil on the non-motor consequences of stroke in young patients and the high safety profile of the drug were shown.Keywords
This publication has 25 references indexed in Scilit:
- Prevalence and Predictors of Fatigue and Neuropsychiatric Symptoms in Patients with Minor Ischemic StrokeJournal of Stroke and Cerebrovascular Diseases, 2021
- Association between neurological outcome and poststroke comorbid mood and anxiety disorders: A real‐life experienceBrain and Behavior, 2021
- Temporal Trends in the Risk Factors and Clinical Characteristics of Ischemic Stroke in Young AdultsJournal of Stroke and Cerebrovascular Diseases, 2020
- Model of Understanding Fatigue After StrokeStroke, 2015
- Long-Term Cognitive Impairment After First-Ever Ischemic Stroke in Young AdultsStroke, 2013
- Duloxetine Versus Citalopram and Sertraline in the Treatment of Poststroke Depression, Anxiety, and FatigueThe Journal of Neuropsychiatry and Clinical Neurosciences, 2012
- Fluoxetine Is Not Effective in the Treatment of Poststroke Fatigue: A Double-Blind, Placebo-Controlled StudyCerebrovascular Diseases, 2006
- Cytidinediphosphocholine (CDP-choline) for cognitive and behavioural disturbances associated with chronic cerebral disorders in the elderlyCochrane Database of Systematic Reviews, 2005
- The Montreal Cognitive Assessment, MoCA: A Brief Screening Tool For Mild Cognitive ImpairmentJournal of the American Geriatrics Society, 2005
- The multidimensional Fatigue Inventory (MFI) psychometric qualities of an instrument to assess fatigueJournal of Psychosomatic Research, 1995